跳至主要内容
临床试验/NCT03395418
NCT03395418已完成不适用

Evaluation of the Right Use of Inhaled Therapeutics Prescribed in Asthma and COPD in Adults

Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Percentage of exploitable films

研究概览

简要总结

Asthma and COPD have a significant impact on public health, affecting about 8 million people in France and generating health care costs of 5.5 billion euros, almost 50% of which are dedicated to long-term treatments are essentially inhaled therapies.

The good control of the disease depends on the patient's compliance, but also on the proper use of the devices used for the administration of inhaled drugs under penalty of the degradation of the control of the disease with major medical and medico-economic consequences.

Thus, education of these patients in the use of devices must be an integral part of medical care. It comes up against the complexity of the therapeutic arsenal on the one hand and on the other hand with its time-consuming nature: this makes it incompatible with a realization in consultation.

The "ARGOS" process is a telemonitoring project for the support of therapeutic education, consisting in setting up a concrete and real-time relay between prescribers and patients for the education of inhaled therapeutics.

Its objective is to provide the answer to what is currently an "unmet need" in the management of asthma and COPD, with the prospect of a positive impact on the observance of these treatments and by consequently their clinical and economic efficiency.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient followed in Pneumology for asthma or COPD with a prescription for long-term inhaled therapies AND a home health provider (who monitors either home oxygen and / or respiratory equipment)
  • The patient must have a means of telephone communication in order to be able to be contacted by a provider, an H2AD permanence or a doctor
  • Patient having given his agreement after having been informed in writing of the purpose and the data collected during this study
  • Age ≥ 18 years
  • Beneficiary of a social security scheme

排除标准

  • Refusal of the patient
  • Patient not understanding French
  • Absence of home health provider
  • Absence of means of telephone communication

结局指标

主要结局

Percentage of exploitable films

时间窗: Day 1 to day 7

Ratio between the number of exploitable films and the number of films arriving at the telemedicine platform.

次要结局

未报告次要终点

研究者

发起方
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验